Background There are few reports that examine the current imaging and management techniques according to the severity of acute pulmonary embolism (APE) or that clarify whether the management strategy ameliorated the mortality from APE.
cute pulmonary embolism (APE) is potentially fatal, [1] [2] [3] and although the number of cases in Japan is lower than in Western countries, the incidence has been increasing in recent years. [4] [5] [6] Many techniques to decrease mortality have been tried, including the use of heparin, 7 thrombolytic therapy, [8] [9] [10] [11] surgical embolectomy, percutaneous cardiopulmonary support (PCPS), 12 catheter intervention and inferior vena cava (IVC) filter. 13 However, only thrombolytic therapy for hemodynamically unstable patients 8 and heparin 7 have been shown to effectively reduce mortality. Recently, computed tomography (CT) 14 and magnetic resonance (MR) angiography, 15 in addition to pulmonary angiography and lung scintigraphy, have become useful tools for diagnosing APE. Kasper et al reported that APE patients with cardiogenic collapse underwent diagnostic lung scintigraphy and pulmonary angiography less frequently and thrombolytic therapy more often, 3 and other than that report, more information on the most suitable diagnostic imaging tests and management strategies is required in order to improve the treatment and outcome of APE.
In the United States, 0.1-0.5% of surviving cases of APE progressed to chronic thromboembolic pulmonary hypertension, 16, 17 compared with approximately 30% of patients with pulmonary embolism in Japan becoming chronic. 18, 19 Therefore, the present study was designed to examine the influence of the selection of diagnostic methods and treatments for APE, and to clarify which are more strongly associated with reduced mortality.
Methods

Study Population
The study was performed using data from the third registry (the present registry) of the Japanese Society of Pulmonary Embolism Research (JaSPER) in which 629 patients with pulmonary embolism were enrolled. The cases of APE (461 patients, 73.3%), defined as an acute onset illness of less than 2 weeks duration, were all diagnosed between November 2000 and August 2003 in the participating centers in JaSPER (Appendix 1). . Right ventricular overload was not evaluated in 7 patients without shock and the diagnostic tests were not reported in an additional 4 patients, in total 445 patients with APE were used in the evaluation of the clinical diagnostic tests and 449 patients in that of the therapeutic management according to the severity of the disease.
All decisions concerning the diagnostic workup, treatment, and cause of death, whether for a first APE attack or recurrent APE, were made by the attendant clinicians. The steering committee took care not to influence the management strategy employed in the participating hospitals.
For the comparison with the mortality in the previous registries, the first (between January 1994 and October 1997; 309 APE patients) 21 and second registries (between November 1997 and October 2000; 257 APE patients) 22 were also used.
Data Acquisition
Complete information on the clinical course and the diagnostic and therapeutic modalities of the patients entered into the registry was obtained by means of a standardized questionnaire sent to the participating centers by the steering committee. Data were collected on (1) the severity of APE (Group A = cardiopulmonary arrest, Group B = shock, Group C = right ventricular overload without shock, and Group D = relatively stable state without right ventricular overload nor shock); (2) 30-day mortality after the diagnosis of APE; (3) clinical symptoms and signs of the patients at diagnosis; (4) presence of underlying diseases or predisposing factors for APE; (5) definitive diagnostic procedures given to patients; (6) treatments given to patients; and (7) bleeding complications. Shock was defined as hypotension (systolic blood pressure <90 mmHg or a decrease in systolic blood pressure of at least 40 mmHg during a period of less than 15 min) not caused by newly emergent arrhythmia, hypovolemia or sepsis, accompanied by clinical signs of organ hypoperfusion and hypoxia (eg, impaired consciousness, urine output <30 ml/h, cold and clammy extremities). 23 The patients were defined as having right ventricular overload when echocardiography showed right ventricular dilatation (ie, the right ventricle appearing larger than the left ventricle from the apical or subcostal view; paradoxical septal wall motion; loss of inspiratory collapse of the inferior vena cava; tricuspid regurgitation jet velocity >2.8 m/s, or >2.5 m/s in the absence of inspiratory collapse of the inferior vena cava without evidence of mitral valve disease or left ventricular dysfunction; or diagnosis of precapillary pulmonary hypertension (mean pulmonary artery pressure >20 mmHg in the presence of normal pulmonary capillary wedge pressure) by catheterization of the right side of the heart). 23 
Statistical Analysis
Statistical analysis was carried out using StatView 5.0 (SAS Institute Inc, Cary, NC, USA). All continuous variables were expressed as mean ± standard deviation. Nonordinal categorical data were analyzed by chi-square statistics, and ordinal categorical data by Mann-Whitney test. We also used multiple logistic regression analysis. The results of the logistic regression models are presented as estimated odds ratios with the corresponding 95% confidence intervals (CI). Survival data were analyzed by log rank test. All significant tests were two-tailed.
Results
Severity and Mortality From APE
Groups A, B, C and D consisted of 21, 77, 225 and 126 patients, respectively. In Group A, 5 patients were not diagnosed before death, and 11 patients in Group A (52.4%), 12 in Group B (15.6%), 6 in Group C (2.7%), and 1 in Group D (0.8%) died within 30 days of the diagnosis (p<0.0001) ( Table 2 ). Cumulative survival curves are shown in Fig 1 . In Group A, 2 patients showed consciousness levels of 300, 2 continued to have disturbances of mental capacity, and only 6 patients had no residual brain dysfunction 30 days after diagnosis. Mortality has reduced in recent years because of a decrement in the ratio of severe cases (cases with cardiopulmonary arrest or shock were 35.9%, 30.7% and 22.3% in the first, second and third surveys, respec- tively (p=0.0003)). When analyzing after stratification, the mortality in both severe cases and less severe cases was unchanged between the 3 surveys (Table 3) .
Diagnostic Techniques D-dimer was examined in 80.4% of patients whose onset occurred before admission and 70.5% of patients whose onset occurred in hospital (p=0.015). A high level of Ddimer (≥500 ng/ml) was found in 95.9% of the pre-admission cases and in 96.3% of the in-hospital cases (p>0.99).
The diagnostic imaging techniques used according to the severity are shown in Table 4 . Pulmonary angiography and trans-thoracic echocardiography were chosen for the more severe cases, and perfusion and ventilation lung scans were used in the less severe cases. CT was employed regardless of the severity of APE. Deep vein thrombosis (DVT) was less frequently sought in the severe patients.
Management
The types of management strategies according to the severity are shown in Table 5 . Thrombolysis, PCPS, surgical embolectomy, cardiotonic agents, artificial ventilation and catheter therapy were used in the severe cases, but the use of heparin and IVC filters was independent of the Catheter intervention was performed in 48 patients (catheter thrombectomy alone in 14, mechanical fragmentation alone in 7, and both in 27). Bleeding complications occurred in 57 cases (Table 6 ) and heparin-induced thrombocytopenia in 4 cases. The use of IVC filters was the only type of management technique that reduced the mortality from APE (Table 7) . Multiple logistic analysis in cases excluding Group A also showed that IVC filters lowered the mortality from APE (odds ratio, 0.22; 95% CI 0.047-0.99; p=0.049). Three patients with implanted IVC filters died: 1 in Group A after the first attack, 1 in Group B from cerebral bleeding, and 1 in Group C from cancer. None of the patients with an implanted IVC filter died from recurrent APE within 30 days of diagnosis, compared with 5 patients without a filter (p=0.16).
Deep vein thrombosis (DVT) was searched for using lower limb venous compression ultrasonography, computed tomography (CT), contrast venography, radio-isotope venography or magnetic resonance imaging (MRI). TTE, trans-thoracic echocardiography; TEE
Discussion
The present study shows that the selection of diagnostic methods and treatment was influenced by the severity of APE, and that only inferior vena cava filters lowered the mortality from APE.
Mortality
In general, the mortality from APE has been gradually reducing, but analysis after stratification based on the severity of APE showed no difference in mortality among the 3 registries. The reason for the decreased mortality in the overall cases was that less severe cases are being diagnosed, which also implies that a substantial improvement in the mortality from APE could not be achieved during the 10-year study period. Kasper et al reported a mortality rate of 8.1% in APE with right ventricular overload (Group 1 in their report), 17% in cases with shock (Group 2 and 3), and 65% in cases of cardiogenic collapse (Group 4), 3 and our results are consistent with their data.
As shown in Fig 1, many of the deaths occurred either on the day when APE was diagnosed or the day after, so a therapeutic strategy for this period is needed. Boettiger et al suggested that thrombolytic therapy combined with heparin might improve the mortality in patients with initial, unsuccessful treatment of cardiopulmonary arrest caused by cardiac reasons including pulmonary embolism and myocardial infarction, 24 but negative results have been reported concerning thrombolysis for patients with cardiopulmonary arrest 25 and the efficacy of thrombolytic therapy in this situation remains controversial.
Detailed analysis of the clinical outcomes of the 30-day surviving patients in Group A found that only 6 (28.6% of patients diagnosed before their deaths) did not have residual cerebral damage, so preventing hypoxic injury to the cerebrum is an important problem in cases of cardiopulmonary arrest.
Diagnostic Methods
The efficacy of D-dimer for the diagnosis of APE has been established, especially as a negative predictor. 26, 27 Our study could not address the specificity, but the sensitivity to APE was high enough in both pre-admission and inpatients. It was to be expected that D-dimer was used more frequently in pre-admission patients than for in-patients, because D-dimer is 500 ng/ml or more in many situations other than APE and our study confirmed this in the actual clinical setting.
The present study revealed that the selection of diagnostic methods depended on the severity of APE with respect to some imaging techniques, but not with others. Pulmonary angiography and trans-thoracic echocardiography were more frequently used for the more severe cases, probably because aggressive catheter interventional therapy can follow pulmonary angiography, and trans-thoracic echocardiography can be performed anywhere within a short time. Both ventilation and perfusion lung scans were performed less frequently in the severe cases, which was comparable to previously reported data. 3 There are special situations in Japan in which radioisotopes can be used in restricted areas, and only in an emergency in a very limited number of institutions. On the other hand, CT was widely used to diagnose APE regardless of the severity of the disease. Helical CT can provide immediate images and has similar diagnostic power to pulmonary angiography, which is the gold standard for the diagnosis of APE. 14, 15 Both MR and trans-esophageal echocardiography were used less frequently, and their use did not relate to the severity of APE.
Management
The management of APE was also affected by the initial severity. Heparin and IVC filters were used regardless of the severity, in addition to warfarin in the 30-day surviving cases. In the present study, IVC filters were used more frequently in patients with venous thrombus than in those without, whereas thrombolytic therapy, PCPS, surgical embolectomy, cardiotonic agents, artificial ventilation, and catheter therapy were used more frequently in the more severe cases. Thrombolysis can reduce mortality in cases with unstable hemodynamics 8 and decreases the need for additional therapy and recurrent pulmonary embolism in the acute phase. 10 Our previous study showed that, in patients with right ventricular afterload stress, better outcomes were observed in the thrombolytic group than in the anticoagulation group, although the difference did not reach statistical significance. 23 Therefore, thrombolytic therapy in severe cases may be recommended, although Aklog et al showed that surgical embolectomy was a viable alternative to thrombolytic therapy, which has a risk of fatal bleeding complications. 28 However, the indications for surgical embolectomy still remain to be determined.
We were not able to confirm that heparin and thrombolytic therapy reduced the 30-day mortality from APE, but it was decreased by IVC filter implantation, which implies that IVC filters prevent recurrent pulmonary embolism in the acute phase, thereby saving lives. Contraindications for or complications of anticoagulation accounted for 57.9% of the indications for IVC filters in the report by Athansasoulis et al 29 and these indications have been widely accepted, although IVC filters have been used in patients without those indications; however, the prophylactic use of IVC filters in patients with high risk of APE or venous thrombosis, or as an ancillary treatment for patients using anticoagulant and/or thrombolytic agents remains controversial. 30, 31 In our study, the use of IVC filters was independent of the use of heparin or warfarin in the 30-day surviving cases, but was higher in patients administered thrombolytic agents. Much of the indication for IVC filters in our study was ancillary to other types of treatment, and our data suggested that such use of IVC filters effectively reduced the mortality from APE.
The efficacy of IVC filters needs to be assessed in terms of short-term and long-term results. Our study showed the short-term efficacy of IVC filters in reducing mortality, but did not deal with long-term effects. A randomized control study in patients with acute venous thrombosis showed that IVC filters prevented acute pulmonary re-embolism, but did not reduce mortality from APE. 13 Moreover, in that study IVC filters increased the incidence of DVT 2 years after implantation, although less than 40% of the subjects were symptomatic cases of APE and cases requiring treatment with thrombolytic agents were excluded. 13 White et al showed that IVC filters increased the 1-year cumulative rate of re-hospitalization because of venous thrombosis in patients with primary pulmonary embolism. 32 These findings indicate that the efficacy of IVC filters is reduced in the long-term and therefore the temporary or retrievable type should be chosen, if possible.
We first documented that IVC filters reduced the mortality from APE in the acute phase, but many studies have attempted to assess management strategies and could not demonstrate the efficacy of IVC filters on mortality. Our results on IVC filters may have been influenced by the high rate of severe cases in which thrombolytic agents were used and by the higher rate of IVC filter use compared with those previous reports. 2, 3, 33, 34 There are only 16 prospective studies on IVC filters from 1975 to 2000 and among these, only 1 randomized control study. 30 Generally, the quality of the literature on IVC filters is low and more detailed studies are needed to address the types of patients that would benefit from filter implantation, what type of filter would be best, and whether combined treatment using IVC filters and thrombolytic therapy is superior to the use of either alone.
Conclusions
In the present study the severity of APE at diagnosis affected the selection of both diagnostic and management techniques. Only implantation of IVC filters reduced the mortality from APE, at least in the short term.
